Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells.
Toshimitsu TanakaHironori KogaHiroyuki SuzukiHideki IwamotoTakahiko SakaueAtsutaka MasudaToru NakamuraJun AkibaHirohisa YanoTakuji TorimuraTakumi KawaguchiPublished in: Hepatology international (2023)
Therapeutic anti-PD-L1 antibodies promote cell proliferation by stabilizing the PD-L1-AXL complex in PD-L1-abundant neoplasms, including in HCC with mesenchymal components. Such a mechanism may contribute to the development of hyperprogressive disease.